Search

Search Constraints

You searched for: Author/Creator Aprile, Giuseppe

Search Results

91. The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors. (November 2015)

92. The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients. Issue 2 (4th February 2019)

93. The Italian Rare Pancreatic Exocrine Cancer Initiative. Issue 4 (August 2019)

94. The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte‐to‐Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer. (23rd March 2020)

95. The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer. (11th December 2019)

96. The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer. Issue 8 (November 2020)

97. Translational challenges from the 2014 Gastrointestinal Cancers Symposium: toward a true tailored therapy through effective research. (May 2014)

98. Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial. Issue 4 (April 2020)

99. Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 7 (July 2022)